Trogenix News and Activities

Acquisition, funding and merger involving Trogenix.

• Trogenix has just announced a $95 Million fundraising (posted on October 7 2025).

View the org chart displaying its 7 main executives

Most searched biographies at Trogenix

• Ken Macnamara, Chief Executive Officer
• Dima Kuzmin, Chairman of the Board
• Bryn Dixon, Vice President, Clinical Development

Popular executive movements at Trogenix

• Atif Abbas, Chief Medical Officer, has left the company  (posted on April 8 2026).

Create your alert
to follow the executive moves at Trogenix.

Trogenix has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Trogenix

Social media about Trogenix

• Trogenix on Wikipedia, Google News & Yahoo Finance
• Trogenix on LinkedIn, X (Twitter) & YouTube